Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Drug Safety|January 17, 2019
Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled AsthmaMats Carlsson, Martin Braddock, Yuling Li, et al.
Oncotarget|December 31, 2015
Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resectionGui-Qian Huang, Gui-Qi Zhu, Yan-Long Liu, et al.
Pharmacology Research & Perspectives|October 31, 2015
In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinibMichael G Rolf, Jon O Curwen, Margaret Veldman-Jones, et al.
Rheumatology (Oxford, England)|July 28, 2014
The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cellsAndrew M Platt, Robert A Benson, Ross McQueenie, et al.
Pharmacology Research & Perspectives|October 31, 2015
Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agentsDave Lengel, Eva Lamm Bergström, Herb Barthlow, et al.
Expert Review of Gastroenterology & Hepatology|November 13, 2015
The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological interventionHai Zou, Chu-Xiao Shao, Qin-Yun Zhou, et al.
Medicine|January 9, 2015
Systematic review with network meta-analysis: adjuvant chemotherapy for resected colorectal liver metastasesGui-Qi Zhu, Jie You, Ke-Qing Shi, et al.
Expert Review of Gastroenterology & Hepatology|April 20, 2016
Targeting endoplasmic reticulum stress in liver diseaseFa-Ling Wu, Wen-Yue Liu, Sven Van Poucke, et al.
Expert Opinion on Therapeutic Targets|February 14, 2008
CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseasesMing-Hua Zheng, Dian-Na Gu, Martin Braddock, et al.
Oncotarget|February 20, 2016
Parabolic relationship between sex-specific serum high sensitive C reactive protein and non-alcoholic fatty liver disease in Chinese adults: a large population-based studyLi-Ren Wang, Wen-Yue Liu, Sheng-Jie Wu, et al.
Pageof 8